Skip to main content
Erschienen in: Infection 6/2017

30.08.2017 | Original Paper

Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients

verfasst von: M. Diab, C. Sponholz, C. von Loeffelholz, P. Scheffel, M. Bauer, A. Kortgen, T. Lehmann, G. Färber, M. W. Pletz, T. Doenst

Erschienen in: Infection | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Infective endocarditis (IE) is often associated with multiorgan dysfunction and mortality. The impact of perioperative liver dysfunction (LD) on outcome remains unclear and little is known about factors leading to postoperative LD.

Methods

We performed a retrospective, single-center analysis on 285 patients with left-sided IE without pre-existing chronic liver disease referred to our center between 2007 and 2013 for valve surgery. Sequential organ failure assessment (SOFA) score was used to evaluate organ dysfunction. Chi-square, Cox regression, and multivariate analyses were used for evaluation.

Results

Preoperative LD (Bilirubin >20 μmol/L) was present in 68 of 285 patients. New, postoperative LD occurred in 54 patients. Hypoxic hepatitis presented the most common origin of LD, accompanied with high short-term mortality. In-hospital mortality was higher in patients with preoperative and postoperative LD compared to patients without LD (51.5, 24.1, and 10.4%, respectively, p < 0.001). 5-year survival was worse in patients with pre- or postoperative LD compared to patients without LD (20.1, 37.1, and 57.0% respectively). A landmark analysis revealed similar 5-year survival between groups after patient discharge. Quality of life was similar between groups when patients survived the perioperative period. Logistic regression analysis identified duration of cardiopulmonary bypass and S. aureus infection as independent predictors of postoperative LD.

Conclusions

Perioperative liver dysfunction in patients with infective endocarditis is an independent predictor of short- and long-term mortalities. After surviving the hospital stay, 5-year prognosis is not different and quality of life is not affected by LD. S. aureus and duration of cardiopulmonary bypass represent risk factors for postoperative LD.
Literatur
1.
Zurück zum Zitat Keynan Y, Singal R, Kumar K, Arora RC, Rubinstein E. Infective endocarditis in the intensive care unit. Crit Care Clin. 2013;29:923–51.CrossRefPubMed Keynan Y, Singal R, Kumar K, Arora RC, Rubinstein E. Infective endocarditis in the intensive care unit. Crit Care Clin. 2013;29:923–51.CrossRefPubMed
2.
Zurück zum Zitat Diab M, Guenther A, Sponholz C, Lehmann T, Faerber G, Matz A, et al. Pre-operative stroke and neurological disability do not independently affect short- and long-term mortality in infective endocarditis patients. Soc: Clin Res Cardiol; 2016. Diab M, Guenther A, Sponholz C, Lehmann T, Faerber G, Matz A, et al. Pre-operative stroke and neurological disability do not independently affect short- and long-term mortality in infective endocarditis patients. Soc: Clin Res Cardiol; 2016.
3.
Zurück zum Zitat Ferreira JP, Gomes F, Rodrigues P, Araújo Abreu M, Maia JM, Bettencourt P, et al. Left-sided infective endocarditis: analysis of in-hospital and medium-term outcome and predictors of mortality. Rev Port Cardiol. 2013;32:777–84.PubMed Ferreira JP, Gomes F, Rodrigues P, Araújo Abreu M, Maia JM, Bettencourt P, et al. Left-sided infective endocarditis: analysis of in-hospital and medium-term outcome and predictors of mortality. Rev Port Cardiol. 2013;32:777–84.PubMed
4.
Zurück zum Zitat Tornos P, Gonzalez-Alujas T, Thuny F, Habib G. Infective endocarditis: the European viewpoint. Curr Probl Cardiol. 2011;36:175–222.CrossRefPubMed Tornos P, Gonzalez-Alujas T, Thuny F, Habib G. Infective endocarditis: the European viewpoint. Curr Probl Cardiol. 2011;36:175–222.CrossRefPubMed
5.
Zurück zum Zitat Samol A, Kaese S, Bloch J, Görlich D, Peters G, Waltenberger J, et al. Infective endocarditis on ICU: risk factors, outcome and long-term follow-up. Infection. 2015;43:287–95.CrossRefPubMed Samol A, Kaese S, Bloch J, Görlich D, Peters G, Waltenberger J, et al. Infective endocarditis on ICU: risk factors, outcome and long-term follow-up. Infection. 2015;43:287–95.CrossRefPubMed
6.
Zurück zum Zitat Seminari E, De Silvestri A, Ravasio V, Ludovisi S, Utili R, Petrosillo N, et al. Infective endocarditis in patients with hepatic diseases. Eur J Clin Microbiol Infect Dis. 2016;35:279–84.CrossRefPubMed Seminari E, De Silvestri A, Ravasio V, Ludovisi S, Utili R, Petrosillo N, et al. Infective endocarditis in patients with hepatic diseases. Eur J Clin Microbiol Infect Dis. 2016;35:279–84.CrossRefPubMed
7.
8.
Zurück zum Zitat Recknagel P, Gonnert FA, Westermann M, Lambeck S, Lupp A, Rudiger A, et al. Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med. 2012;9:e1001338.CrossRefPubMedPubMedCentral Recknagel P, Gonnert FA, Westermann M, Lambeck S, Lupp A, Rudiger A, et al. Liver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitis. PLoS Med. 2012;9:e1001338.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Çağlı K, Başar FN, Tok D, Turak O, Başar Ö. How to interpret liver function tests in heart failure patients? Turk J Gastroenterol. 2015;26:197–203.CrossRefPubMed Çağlı K, Başar FN, Tok D, Turak O, Başar Ö. How to interpret liver function tests in heart failure patients? Turk J Gastroenterol. 2015;26:197–203.CrossRefPubMed
10.
Zurück zum Zitat Diaz GC, Renz JF. Cardiac surgery in patients with end-stage liver disease. J Cardiothorac Vasc Anesth. 2014;28:155–62.CrossRefPubMed Diaz GC, Renz JF. Cardiac surgery in patients with end-stage liver disease. J Cardiothorac Vasc Anesth. 2014;28:155–62.CrossRefPubMed
11.
Zurück zum Zitat Weis F, Kilger E, Beiras-Fernandez A, Hinske CL, Nassau K, Adnan L, et al. Indocyanine green clearance as an outcome prediction tool in cardiac surgery: a prospective study. J Crit Care. 2014;29:224–9.CrossRefPubMed Weis F, Kilger E, Beiras-Fernandez A, Hinske CL, Nassau K, Adnan L, et al. Indocyanine green clearance as an outcome prediction tool in cardiac surgery: a prospective study. J Crit Care. 2014;29:224–9.CrossRefPubMed
12.
Zurück zum Zitat Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707–10.CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22:707–10.CrossRefPubMed
13.
Zurück zum Zitat Havens JM, Columbus AB, Olufajo OA, Askari R, Salim A, Christopher KB. Association of model for end-stage liver disease score with mortality in emergency general surgery patients. JAMA Surg. 2016;151(7):e160789.CrossRefPubMed Havens JM, Columbus AB, Olufajo OA, Askari R, Salim A, Christopher KB. Association of model for end-stage liver disease score with mortality in emergency general surgery patients. JAMA Surg. 2016;151(7):e160789.CrossRefPubMed
14.
15.
Zurück zum Zitat Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care. 2008;12:R161.CrossRefPubMedPubMedCentral Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: a systematic review. Crit Care. 2008;12:R161.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Kramer L, Jordan B, Druml W, Bauer P, Metnitz PGH, Austrian Epidemiologic Study on Intensive Care, ASDI Study Group. Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med. 2007;35:1099–104.CrossRefPubMed Kramer L, Jordan B, Druml W, Bauer P, Metnitz PGH, Austrian Epidemiologic Study on Intensive Care, ASDI Study Group. Incidence and prognosis of early hepatic dysfunction in critically ill patients—a prospective multicenter study. Crit Care Med. 2007;35:1099–104.CrossRefPubMed
17.
Zurück zum Zitat Kortgen A, Recknagel P, Bauer M. How to assess liver function? Curr Opin Crit Care. 2010;16:136–41.CrossRefPubMed Kortgen A, Recknagel P, Bauer M. How to assess liver function? Curr Opin Crit Care. 2010;16:136–41.CrossRefPubMed
18.
Zurück zum Zitat Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–6.CrossRefPubMed Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124:91–6.CrossRefPubMed
20.
Zurück zum Zitat Collins JD, Bassendine MF, Ferner R, Blesovsky A, Murray A, Pearson DT, et al. Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet. 1983;1:1119–23.CrossRefPubMed Collins JD, Bassendine MF, Ferner R, Blesovsky A, Murray A, Pearson DT, et al. Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet. 1983;1:1119–23.CrossRefPubMed
21.
Zurück zum Zitat Mastoraki A, Karatzis E, Mastoraki S, Kriaras I, Sfirakis P, Geroulanos S. Postoperative jaundice after cardiac surgery. Hepatobiliary Pancreat Dis Int. 2007;6:383–7.PubMed Mastoraki A, Karatzis E, Mastoraki S, Kriaras I, Sfirakis P, Geroulanos S. Postoperative jaundice after cardiac surgery. Hepatobiliary Pancreat Dis Int. 2007;6:383–7.PubMed
22.
Zurück zum Zitat Ramesh Babu CS, Sharma M. Biliary tract anatomy and its relationship with venous drainage. J Clin Exp Hepatol. 2014;4:S18–26.CrossRefPubMed Ramesh Babu CS, Sharma M. Biliary tract anatomy and its relationship with venous drainage. J Clin Exp Hepatol. 2014;4:S18–26.CrossRefPubMed
23.
Zurück zum Zitat Diaz GC, Moitra V, Sladen RN. Hepatic and renal protection during cardiac surgery. Anesthesiol Clin. 2008;26:565–90.CrossRefPubMed Diaz GC, Moitra V, Sladen RN. Hepatic and renal protection during cardiac surgery. Anesthesiol Clin. 2008;26:565–90.CrossRefPubMed
24.
Zurück zum Zitat An Y, Xiao Y-B. Growth hormone prevents acute liver injury induced by cardiopulmonary bypass in a rat model. J Thorac Cardiovasc Surg. 2007;134:342–50.CrossRefPubMed An Y, Xiao Y-B. Growth hormone prevents acute liver injury induced by cardiopulmonary bypass in a rat model. J Thorac Cardiovasc Surg. 2007;134:342–50.CrossRefPubMed
25.
Zurück zum Zitat Huang H, Yin R, Zhu J, Feng X, Wang C, Sheng Y, et al. Protective effects of melatonin and N-acetylcysteine on hepatic injury in a rat cardiopulmonary bypass model. J Surg Res. 2007;142:153–61.CrossRefPubMed Huang H, Yin R, Zhu J, Feng X, Wang C, Sheng Y, et al. Protective effects of melatonin and N-acetylcysteine on hepatic injury in a rat cardiopulmonary bypass model. J Surg Res. 2007;142:153–61.CrossRefPubMed
26.
Zurück zum Zitat Aboelsoud MM, Javaid AI, Al-Qadi MO, Lewis JH. Hypoxic hepatitis—its biochemical profile, causes and risk factors of mortality in critically-ill patients: a cohort study of 565 patients. J Crit Care. 2017;41:9–15.CrossRefPubMed Aboelsoud MM, Javaid AI, Al-Qadi MO, Lewis JH. Hypoxic hepatitis—its biochemical profile, causes and risk factors of mortality in critically-ill patients: a cohort study of 565 patients. J Crit Care. 2017;41:9–15.CrossRefPubMed
27.
Zurück zum Zitat Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011;37:1302–10.CrossRefPubMed Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med. 2011;37:1302–10.CrossRefPubMed
28.
Zurück zum Zitat Jung C, Fuernau G, Eitel I, Desch S, Schuler G, Kelm M, et al. Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock. Clin Res Cardiol. 2017;106:341–9.CrossRefPubMed Jung C, Fuernau G, Eitel I, Desch S, Schuler G, Kelm M, et al. Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock. Clin Res Cardiol. 2017;106:341–9.CrossRefPubMed
29.
Zurück zum Zitat Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Haider DG, et al. Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit. Ann Intensive Care. 2016;6:61.CrossRefPubMedPubMedCentral Drolz A, Horvatits T, Roedl K, Rutter K, Staufer K, Haider DG, et al. Outcome and features of acute kidney injury complicating hypoxic hepatitis at the medical intensive care unit. Ann Intensive Care. 2016;6:61.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Bergin SP, Holland TL, Fowler VG, Tong SYC. Bacteremia, sepsis, and infective endocarditis associated with Staphylococcus aureus. Immunol: Curr Top Microbiol; 2015.CrossRef Bergin SP, Holland TL, Fowler VG, Tong SYC. Bacteremia, sepsis, and infective endocarditis associated with Staphylococcus aureus. Immunol: Curr Top Microbiol; 2015.CrossRef
31.
Zurück zum Zitat Takai S, Higuchi S, Yano A, Tsuneyama K, Fukami T, Nakajima M, et al. Involvement of immune- and inflammatory-related factors in flucloxacillin-induced liver injury in mice. J Appl Toxicol. 2015;35:142–51.CrossRefPubMed Takai S, Higuchi S, Yano A, Tsuneyama K, Fukami T, Nakajima M, et al. Involvement of immune- and inflammatory-related factors in flucloxacillin-induced liver injury in mice. J Appl Toxicol. 2015;35:142–51.CrossRefPubMed
33.
Zurück zum Zitat Verhagen DWM, Hermanides J, Korevaar JC, Bossuyt PMM, van den Brink RBA, Speelman P, et al. Health-related quality of life and posttraumatic stress disorder among survivors of left-sided native valve endocarditis. Clin Infect Dis. 2009;48:1559–65.CrossRefPubMed Verhagen DWM, Hermanides J, Korevaar JC, Bossuyt PMM, van den Brink RBA, Speelman P, et al. Health-related quality of life and posttraumatic stress disorder among survivors of left-sided native valve endocarditis. Clin Infect Dis. 2009;48:1559–65.CrossRefPubMed
34.
Zurück zum Zitat Nayak A, Mundy J, Wood A, Griffin R, Pinto N, Peters P, et al. Surgical management and mid-term outcomes of 108 patients with infective endocarditis. Heart Lung Circ. 2011;20:532–7.CrossRefPubMed Nayak A, Mundy J, Wood A, Griffin R, Pinto N, Peters P, et al. Surgical management and mid-term outcomes of 108 patients with infective endocarditis. Heart Lung Circ. 2011;20:532–7.CrossRefPubMed
35.
Zurück zum Zitat Perrotta S, Aljassim O, Jeppsson A, Bech-Hanssen O, Svensson G. Survival and quality of life after aortic root replacement with homografts in acute endocarditis. Ann Thorac Surg. 2010;90:1862–7.CrossRefPubMed Perrotta S, Aljassim O, Jeppsson A, Bech-Hanssen O, Svensson G. Survival and quality of life after aortic root replacement with homografts in acute endocarditis. Ann Thorac Surg. 2010;90:1862–7.CrossRefPubMed
36.
Zurück zum Zitat Rangnekar AS, Ellerbe C, Durkalski V, McGuire B, Lee WM, Fontana RJ. Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients. Liver Transplant. 2013;19:991–1000.CrossRef Rangnekar AS, Ellerbe C, Durkalski V, McGuire B, Lee WM, Fontana RJ. Quality of life is significantly impaired in long-term survivors of acute liver failure and particularly in acetaminophen-overdose patients. Liver Transplant. 2013;19:991–1000.CrossRef
Metadaten
Titel
Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients
verfasst von
M. Diab
C. Sponholz
C. von Loeffelholz
P. Scheffel
M. Bauer
A. Kortgen
T. Lehmann
G. Färber
M. W. Pletz
T. Doenst
Publikationsdatum
30.08.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 6/2017
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1064-6

Weitere Artikel der Ausgabe 6/2017

Infection 6/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.